Free Trial

Synaptogenix (SNPX) Competitors

Synaptogenix logo
$9.70 -0.69 (-6.60%)
As of 07/15/2025

SNPX vs. KLTO, ADVM, PDSB, ANVS, ANL, GANX, NRXP, ATRA, KRON, and CELU

Should you be buying Synaptogenix stock or one of its competitors? The main competitors of Synaptogenix include Klotho Neurosciences (KLTO), Adverum Biotechnologies (ADVM), PDS Biotechnology (PDSB), Annovis Bio (ANVS), Adlai Nortye (ANL), Gain Therapeutics (GANX), NRx Pharmaceuticals (NRXP), Atara Biotherapeutics (ATRA), Kronos Bio (KRON), and Celularity (CELU). These companies are all part of the "pharmaceutical products" industry.

Synaptogenix vs. Its Competitors

Klotho Neurosciences (NASDAQ:KLTO) and Synaptogenix (NASDAQ:SNPX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, risk, valuation and earnings.

Klotho Neurosciences is trading at a lower price-to-earnings ratio than Synaptogenix, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Klotho NeurosciencesN/AN/A-$6.15M-$0.36-3.56
SynaptogenixN/AN/A-$12.77M-$10.08-0.96

In the previous week, Klotho Neurosciences had 6 more articles in the media than Synaptogenix. MarketBeat recorded 7 mentions for Klotho Neurosciences and 1 mentions for Synaptogenix. Synaptogenix's average media sentiment score of 1.87 beat Klotho Neurosciences' score of 0.59 indicating that Synaptogenix is being referred to more favorably in the news media.

Company Overall Sentiment
Klotho Neurosciences Positive
Synaptogenix Very Positive

20.1% of Klotho Neurosciences shares are held by institutional investors. Comparatively, 10.3% of Synaptogenix shares are held by institutional investors. 26.7% of Klotho Neurosciences shares are held by company insiders. Comparatively, 2.7% of Synaptogenix shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Klotho Neurosciences has a beta of 11.08, indicating that its share price is 1,008% more volatile than the S&P 500. Comparatively, Synaptogenix has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500.

Synaptogenix's return on equity of -115.28% beat Klotho Neurosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Klotho NeurosciencesN/A -1,779.01% -275.01%
Synaptogenix N/A -115.28%-58.31%

Summary

Klotho Neurosciences beats Synaptogenix on 6 of the 10 factors compared between the two stocks.

Get Synaptogenix News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNPX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNPX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNPX vs. The Competition

MetricSynaptogenixMED IndustryMedical SectorNASDAQ Exchange
Market Cap$13.48M$2.90B$5.51B$9.31B
Dividend YieldN/A2.46%4.25%4.10%
P/E Ratio-0.9620.3628.1719.69
Price / SalesN/A302.79438.93100.42
Price / CashN/A42.3835.5357.53
Price / Book2.247.768.225.67
Net Income-$12.77M-$55.11M$3.23B$257.51M
7 Day Performance36.17%0.19%-0.59%-0.16%
1 Month Performance147.32%10.80%6.65%9.89%
1 Year Performance116.41%-0.68%26.87%15.08%

Synaptogenix Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNPX
Synaptogenix
0.3118 of 5 stars
$9.70
-6.6%
N/A+118.4%$13.48MN/A-0.964Positive News
KLTO
Klotho Neurosciences
N/A$1.35
+8.0%
N/AN/A$57.57MN/A-3.75N/A
ADVM
Adverum Biotechnologies
4.402 of 5 stars
$2.63
-3.7%
$23.80
+804.9%
-69.1%$57.03M$1M-0.41190
PDSB
PDS Biotechnology
1.2949 of 5 stars
$1.17
-4.9%
$9.00
+669.2%
-70.8%$56.22MN/A-1.2420News Coverage
ANVS
Annovis Bio
1.5645 of 5 stars
$2.70
-5.8%
$18.00
+567.9%
-77.6%$55.73MN/A-1.253
ANL
Adlai Nortye
2.1051 of 5 stars
$1.57
+4.0%
$9.00
+473.2%
-58.7%$55.72M$5M0.00127Positive News
GANX
Gain Therapeutics
2.3138 of 5 stars
$1.70
-8.6%
$8.20
+382.4%
+24.6%$55.70M$50K-1.9820News Coverage
NRXP
NRx Pharmaceuticals
2.7621 of 5 stars
$3.11
-3.1%
$28.50
+816.4%
+20.4%$55.50MN/A-1.552
ATRA
Atara Biotherapeutics
4.3918 of 5 stars
$9.27
-0.3%
$17.75
+91.5%
-24.4%$55.44M$128.94M-2.49330
KRON
Kronos Bio
N/A$0.88
+1.5%
$1.63
+84.7%
-41.3%$53.72M$9.85M-0.82100
CELU
Celularity
0.1406 of 5 stars
$2.48
+10.7%
N/A-30.5%$53.65M$54.22M-0.94220Upcoming Earnings
Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:SNPX) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners